Argentina vs Cuba: The number of people with susceptibility test result for rifampicin
Argentina
36.41
in 2021
Cuba
40.43
in 2021
Argentina rank
127th
Cuba rank
124th
The number of people with susceptibility test result for rifampicin over time
- Argentina
- Cuba
How they compare
Cuba currently reports 40.43 against 36.41 in Argentina, a difference of 4.02.
That makes Cuba's figure about 1.1 times Argentina's.
Across all 5 years both countries report, Cuba has been ahead every year.
Argentina ranks 127th and Cuba ranks 124th of 146 countries.
Cuba has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Argentina | Cuba | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 22.37 | 66.38 | 44.01 | Cuba |
| 2020s | 30.62 | 45.55 | 14.93 | Cuba |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher the number of people with susceptibility test result for rifampicin, Argentina or Cuba?
- Cuba, at 40.43 against 36.41 in Argentina as of 2021.
- What is the difference in the number of people with susceptibility test result for rifampicin between Argentina and Cuba?
- 4.02, with Cuba ahead.
- How many years of comparable data are there for Argentina and Cuba?
- 5 years are reported by both, from 2017 to 2021.
- How do Argentina and Cuba rank globally for the number of people with susceptibility test result for rifampicin?
- Argentina ranks 127th and Cuba ranks 124th of 146 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients expressed as percentage.. Statizoid refreshes it automatically from the source and publishes the full history for both places.